⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TVRD News
Tvardi Therapeutics, Inc. Common Stock
Tvardi Therapeutics Announces Third Quarter 2025 Results and Provides Business Update
businesswire.com
TVRD
Tvardi Therapeutics, Inc. (TVRD) Under Investigation for Potential Securities Law Violations - Contact Levi & Korsinsky Today
accessnewswire.com
TVRD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tvardi Therapeutics, Inc. - TVRD
accessnewswire.com
TVRD
Investigation Opened on Behalf of Tvardi Therapeutics, Inc. (TVRD) Shareholders - Contact Levi & Korsinsky
accessnewswire.com
TVRD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tvardi Therapeutics, Inc. - TVRD
accessnewswire.com
TVRD
Levi & Korsinsky Investigating Whether Tvardi Therapeutics, Inc. (TVRD) Misled Investors - Securities Law Violations Possible
accessnewswire.com
TVRD
ATTENTION TVRD Investors: Securities Fraud Investigation Underway - Contact Levi & Korsinsky
accessnewswire.com
TVRD
Tvardi Therapeutics, Inc. (TVRD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
TVRD
Levi & Korsinsky Investigates Tvardi Therapeutics, Inc. (TVRD) Over Possible Securities Fraud
accessnewswire.com
TVRD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tvardi Therapeutics, Inc. - TVRD
accessnewswire.com
TVRD